Acadia Pharmaceuticals Inc
Nasdaq · Healthcare · Pharmaceutical Preparations · San Diego, CA
ACAD chart
What traders are saying about $ACAD
Latest postsAcadia Pharmaceuticals Inc news
- Why Acadia Pharmaceuticals Fell Even As Profit Rose
Simply Wall Street ·
- Acadia Pharmaceuticals (ACAD) Stock Dropped, So What Is Driving Attention Now?
Simply Wall Street ·
- Acadia Pharmaceuticals announces retirement of R&D head, names interim consultant
Investing.com ·
- ACADIA Pharmaceuticals Inc. Estimates – NASDAQ:ACAD
TradingView ·
- Form 8K ACADIA Pharmaceuticals Inc For: 23 October By Investing.com
Investing.com Nigeria ·
- ACADIA Pharmaceuticals Inc. (ACAD) Stock Forecasts
Yahoo Finance ·
- Acadia Pharmaceuticals to report Q3FY26 results on November 4
scanx.trade ·
- Press Release: Acadia Pharmaceuticals to Announce Third Quarter 2026 Financial Results on November 4, 2026
Moomoo ·
- Acadia Pharmaceuticals to Announce Third Quarter 2026 Financial Results on November 4, 2026
Yahoo Finance ·
- Will Auvelity Continue to Aid Axsome's Top-Line Growth in Q3?
Yahoo Finance ·
- Top Midday Decliners
Yahoo Finance ·
- Can Nuplazid and Daybue Strengthen Acadia's Growth Prospects?
Yahoo Finance ·
Acadia Pharmaceuticals Inc key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $1.07B | $957.8M | $726.4M | $517.2M |
| Net income | $391.0M | $226.0M | -$61.0M | -$214.0M |
| Diluted EPS | $2.30 | $1.36 | $-0.37 | $-1.34 |
| Total assets (year end) | $1.56B | $1.19B | $749.0M | $587.8M |
| Cash and equivalents (year end) | $177.7M | $319.6M | $188.7M | $114.8M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Acadia Pharmaceuticals Inc
- Ticker
- ACAD (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- San Diego, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1070494
Frequently asked questions
What exchange is Acadia Pharmaceuticals Inc listed on?
Acadia Pharmaceuticals Inc trades on the Nasdaq under the ticker symbol ACAD.
What industry is Acadia Pharmaceuticals Inc in?
Acadia Pharmaceuticals Inc is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Acadia Pharmaceuticals Inc headquartered?
Acadia Pharmaceuticals Inc's business address on file with the SEC is in San Diego, CA.
When does Acadia Pharmaceuticals Inc's fiscal year end?
Acadia Pharmaceuticals Inc's fiscal year ends on December 31.
How much revenue did Acadia Pharmaceuticals Inc report?
Acadia Pharmaceuticals Inc reported $1.07B in revenue for calendar year 2025, according to its SEC filings.